Advanced Micro Devices vs. Qualcomm: Which Technology Stock Is a Better Buy in 2026?

AMD reported FY2025 revenue of about $34.6B, up roughly 34%, and the article favors AMD over Qualcomm despite AMD’s much higher forward P/E (84.5x vs. 17.5x). It cites expected AMD sales of $49.6B, up more than 40% year over year, and management’s forecast that AI-chip demand will grow over 30% annually. Qualcomm raised its non-handset revenue target to more than $40B by 2029, but the article highlights handset-market risks and treats its potential OpenAI smartphone-chip role as speculative.

Analysis

The key asymmetry is expectations, not simply growth versus value: AMD’s much higher forward multiple leaves less room for any delay in OpenAI deployments, product competitiveness, or capacity. Treat the deal and management’s AI-demand outlook as upside scenarios until orders, shipments, and recognized revenue corroborate them. A miss or slower ramp could compress AMD’s multiple even if sales continue growing; execution would need to sustain exceptional growth to defend it. NVIDIA is exposed to share or pricing pressure if AMD becomes a credible alternative, but the article provides no evidence yet of a material displacement.

Qualcomm’s low relative multiple may offer downside cushioning, but its diversification targets are not equivalent to contracted, profitable revenue. Handset weakness and Apple’s potential modem insourcing are nearer-term risks; automotive, industrial, and data-center programs are longer-dated offsets. A proposed OpenAI smartphone-chip relationship is especially speculative. Do not price it as a hedge against Apple insourcing without confirmation of product, timing, and volumes.

Near term, AMD is vulnerable to an expectations reset; over 1–3 months, track guidance and evidence of AI-chip deliveries. Over 6–18 months, the test is whether AMD’s AI business scales without margin dilution or customer-designed silicon displacing merchant chips. For Qualcomm, verify non-handset revenue conversion and handset trends. The valuation figures are source-dependent and should be refreshed before trading. A contrarian relative-value setup is possible, but neither name is a clean hedge for the other: handset and accelerator economics differ, and AMD’s growth can justify a premium if delivery is proven.

Key Decisions for Investors

• Avoid chasing AMD solely on the article’s bullish narrative. Add exposure only after confirming shipment, revenue, and guidance conversion; thesis weakens materially if AI growth expectations are cut or deliveries slip.
• Consider a modest, beta-adjusted long QCOM / short AMD relative-value position only if refreshed valuation data still show a wide gap and Qualcomm handset results stabilize. This is a valuation trade, not a direct business hedge; exit if QCOM handset weakness deepens or AMD materially beats and raises outlook.
• Monitor AMD’s next guidance and disclosed AI revenue/delivery indicators, plus Qualcomm’s handset performance and evidence that non-handset programs are producing revenue. Treat OpenAI-related claims as unverified until product and commercial terms are confirmed.
• Do not use GFS as an assumed direct AMD AI-capacity proxy: verify which foundries and process nodes serve the relevant products before positioning around supply constraints.